Motzer, R. J., Hudes, G., Wilding, G., Schwartz, L. H., Hariharan, S., Kempin, S., . . . Figlin, R. A. (2009). Phase I Trial of Sunitinib Malate plus Interferon-α for Patients with Metastatic Renal Cell Carcinoma.
Dyfyniad Arddull ChicagoMotzer, Robert J., Gary Hudes, George Wilding, Lawrence H. Schwartz, Subramanian Hariharan, Susan Kempin, Rana Fayyad, and Robert A. Figlin. Phase I Trial of Sunitinib Malate Plus Interferon-α for Patients With Metastatic Renal Cell Carcinoma. 2009.
Dyfyniad MLAMotzer, Robert J., et al. Phase I Trial of Sunitinib Malate Plus Interferon-α for Patients With Metastatic Renal Cell Carcinoma. 2009.
Rhybudd: Mae'n bosib nad yw'r dyfyniadau hyn bob amser yn 100% cywir.